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Abstract
The use of nanoparticles in biomedical fields is a very promising scientific 
area and has aroused the interest of researchers in the search for new biode-
gradable, biocompatible and non-toxic materials. This chapter is based on the 
features of the biopolymer silk fibroin and its applications in nanomedicine. 
Silk fibroin, obtained from the Bombyx mori silkworm, is a natural polymeric 
biomaterial whose main features are its amphiphilic chemistry, biocompatibility, 
biodegradability, excellent mechanical properties in various material formats, 
and processing flexibility. All of these properties make silk fibroin a useful 
candidate to act as nanocarrier. In this chapter, the structure of silk fibroin, its 
biocompatibility and degradability are reviewed. In addition, an intensive review 
on the silk fibroin nanoparticle synthesis methods is also presented. Finally, the 
application of the silk fibroin nanoparticles for drug delivery acting as nanocar-
riers is detailed.
Keywords: silk fibroin, structure, biocompatibility, nanoparticle, synthesis, 
nanocarrier
1. Introduction
Silk is an ancestral material used since 2450 BC [1] for making fabrics. After 
having been an economic engine of several empires and coining the name to the 
trade route that linked Asia, Europe and Africa, silk suffered a debacle in the early 
20th century when the much cheaper synthetic polymers derived from hydro-
carbons were introduced. However, today, motivated by its biocompatibility and 
excellent mechanical properties, researchers around the world are trying to produce 
biomaterials based on this biopolymer for a variety of biomedical applications: 
films with a surface roughness that increase cell adhesion, 3D structures for bone 
implants, hydrogels for wound protection and nanoparticles for drug delivery, 
among others [2–5].
Silk fibroin probably receives a lot of attention from the general public due to 
its mechanical properties, so a brief text will be devoted to comparing them with 
other natural fibers and engineering materials. Table 1 shows values of stress at 
break, elasticity and percentage of nominal deformation at the break of silk fibroin 
together with the values of other biomaterials and synthetic materials. Excluding 
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mineralized biomaterials (bones), Kevlar and carbon fibers, Bombyx mori silk 
fibroin together with Nephila clavipes spider silk are the biomaterials with the 
highest stress at break. While the list of biomaterials is incomplete, it is fair to say 
that fibroins are among the strongest polymeric biomaterials known. However, 
the tensile strength of fibroin is substantially lower than that of Kevlar and carbon 
fiber, engineering materials that are commonly used to transmit and support tensile 
forces. At first glance, we could infer that fibroin is superior to other biomateri-
als, such as collagen, but not as “good” as Kevlar and carbon fibers. However, this 
interpretation is based on the assumption that “good” means stiff and strong. 
Looking closely at Table 1, it can be seen that fibroin is quite extensible, presenting 
a maximum deformation of approximately 18%, while engineering materials fail in 
deformations of the order of 1–3%. The great extensibility of fibroin makes it more 
resistant than engineering materials.
It is especially notable that silkworms can produce strong and stiff fibers at room 
temperature and from an aqueous solution, while synthetic materials with comparable 
properties must be processed at elevated high temperatures and/or with less benign 
solvents. Furthermore, synthetic polymer fibers typically require post-spin stretching 
to ensure the necessary degree of molecular orientation in their structure [11]. On the 
other hand, this is not necessary for silk in the natural spinning process. This is due to 
its impressive amino acid sequence which gives rise to an extraordinary polymorphic 
secondary structure that will be discussed below.
2. Silk structure
Silk is a protein biopolymer synthesized by a wide variety of lepidoptera and 
arachnids in specialized glands. However, it is important to note that this chapter focuses 
on silk fibroin from the silkworm Bombyx mori of the Bombycidae family, fed only with 
mulberry leaves (Morus alba L). This is important because the amino acid sequence 




% nominal strain at 
break
Ref.
Silk B. Mori (with sericin) 500 5–12 19 [6]
Silk fibroin B. mori 610–690 15–17 4–16 [6]
Spider silk N. clavipes 875–972 11–13 17–18 [7]
Collagena 0.9-7.4 0.0018-0.046 24–68 [8]
Collagenb 42-72 0.4-0.8 12–16 [8]
PLAc 28-50 1.2-3.0 2–6 [9]
Tendon (mostly collagen) 150 1.5 12 [10]
Bone 160 20 3 [10]
Kevlar (49 fibers) 3600 130 2.7 [10]
Carbon fiber 4000 300 1.3 [10]
Synthetic rubber 50 0.001 850 [10]
aType I collagen fibers extruded from rat tail tested after stretching from 0–50%.
bCross-linked rat tail collagen tested after stretching from 0–50%.
cPolylactic acid with molecular weights ranging from 50,000 to 300,000 units.
Adapted from reference (5) with permission of Elsevier.
Table 1. 
Comparison of the mechanical properties of different natural and synthetic fibers.
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varies from species to species and with it its mechanical and physicochemical properties, 
which can have great implications in different applications.
Silk proteins are synthesized in a gland that extends through the abdomen of 
the worm and is divided into three sections, posterior, middle and anterior, as 
illustrated in Figure 1. The posterior gland cells secrete silk fibroin, reaching a 
concentration of approximately 12% by weight. At this time, the protein is in a 
water-soluble state [13], with a partially ordered secondary structure composed 
of irregular structures and type II β-turns [14], commonly known as silk I. This 
protein is pushed into the gland media, where cells lining the lumen secrete seri-
cin along with other flavonoids (assimilated by worms in the diet) [15]. Fibroin 
and sericin are concentrated to 25% by weight and are driven to the anterior 
gland where they experience pH gradients (maintained through the secretion of 
carbonic anhydrase) and ionic strength gradients. These factors contribute to 
the elongation of fibroin (at this point 30% by weight) into two thin filaments 
and promote the crystallization of repetitive domains. Lastly, during the spin-
ning process, the non-Newtonian protein solution is subjected to crystallization 
induced by changes in pH and ionic strength through the gland [16] and by the 
shear stress generated by an opposing pressure front to the flow, generating a 
velocity gradient from the inlet (0.334 mm/s) to the outlet (13.8 mm/s) of the 
spinning organ [17]. Throughout the process, the silk fibroin initially secreted 
with a partially ordered structure (silk I) undergoes a transition to one composed 
mainly (58%) [18] by antiparallel β sheets, adopting an insoluble crystalline 
structure known as silk II [18, 19].
To understand the formidable properties of this biopolymer, its structure must 
be studied in detail. A silk cocoon is composed of a single silk fiber between 1000 
and 1500 m in length with a diameter of between 10 and 25 μm [20]. This fiber is 
composed of a core of two fibroin filaments, each one of approximately 10 μm cov-
ered by a layer of sericin that hold the fibers together, as illustrated in Figure 2 left, 
providing greater resistance to the assembly of the fiber. In turn, fibroin fibers are 
Figure 1. 
Diagram of the silk fibroin gland. From reference [12] with permission of public library of science (PLOS).
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composed of coiled nanofibrils of between 20 and 25 nm, which gives them greater 
tensile strength (Figure 2, right) [23].
Fibroin, representing approximately 75% of the weight of the cocoon, is a linear, 
water-insoluble protein with high tensile strength. On the other hand, sericin rep-
resents approximately 25% of the cocoon weight, it is a globular, water-soluble pro-
tein whose function is to keep the fibroin fibers together [24]. Silk fibroin is made 
up of three components, a heavy chain (391 kDa) and a light chain (26 kDa) linked 
by a disulfide bridge, and a glycoprotein, P25 (25–30 kDa) in a 6: 6: 1 molar ratio 
to yield a 6.3 MDa megastructure [25]. The primary structure of the silk fibroin 
heavy chain is schematically represented in Figure 3A. This chain is composed of 
5,263 amino acids divided into N- and C-terminal domains, both hydrophilic, and 
Figure 2. 
Left, scanning electron microscope image (2,000X magnification) of silk fiber, containing two fibroin fibers 
coated by sericin. From reference [21] with permission of Elsevier. Right, schematic representation of the 
structure of silk fibroin. Insets show the general structure of the fibrils and the alignment of the antiparallel 
β-sheets. From reference [22] with permission of John Wiley and Sons.
Figure 3. 
Organization of the amino acid sequence within silk fibroin. A) In green and magenta, the N- and C-terminal 
domains are shown, respectively. The repetitive sequences of the GAGAGS type that give rise to the crystalline 
domains of the silk fibroin are represented by orange cylinders and in blue, the hydrophilic sequences that flank 
the crystalline regions. B) Diagram representing the transition from water-soluble silk (silk I) to crystalline 
silk fibers after the bio-spinning process. In silk fiber, amorphous regions (44%) and crystalline regions rich 
in antiparallel β sheets (56%) are represented. Reprinted with permission from reference [26]. Copyright 2020 
American Chemical Society.
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12 hydrophobic domains flanked by 11 short and hydrophilic domains. The hydro-
phobic domains contain highly conserved and repetitive sequences of the GAGAGS, 
GAGAGY, and GAGAGVGY types that form the β-sheet structures that, in addition, 
are packaged in crystalline areas [16]. 86% of the amino acids of the heavy chain of 
fibroin are Glycine (45%), Alanine (29%) and Serine (12%) [27], which are mostly 
found in the hydrophobic and highly repetitive regions. The great bias that the 
primary sequence of fibroin presents towards amino acids with small residues such 
as Glycine and Alanine, promotes the formation of antiparallel β-sheets, which are 
mostly packed in the crystalline areas.
The secondary structure of fibroin contains approximately a total of 58% of 
β-sheet [28], of which approximately 33% correspond to antiparallel β-sheets 
organized in crystalline structures. Fibroin fibers are generally described as a matrix 
of disordered structures with β-sheet crystals embedded in it [26], as represented in 
Figure 3B. The intra and intermolecular hydrogen bond network provide strength 
and tensile strength to the biopolymer, while amorphous regions provide flexibility 
and elasticity [29]. In the literature, there is great variability in the sizes reported 
for these crystals [30–33]. To illustrate the size of these, reference can be made to 
X-ray diffraction measurements and low voltage transmission electron microscopy 
performed by Drummy et al. [30]. They have determined that the crystals within 
the fibroin fibers have dimensions of 21 x 6 x 2 nm and their major axis is aligned 
parallel to the axis of the fibers.
The secondary structure of fibroin with silk II conformation is extremely stable 
thanks to a large number of hydrogen bonds which makes it insoluble in most solvents, 
including under moderate acidic and alkaline conditions. As the content of acidic and 
basic groups is low in fibroin, the electrostatic factor is not decisive in the formation of 
the secondary structure, however, it can be decisive in the dissolution of fibroin. The 
secondary structure of fibroin is not only relevant in the biomaterial synthesis process 
due to the need for its dissolution, but also due to its influence on the mechanical and 
physicochemical properties of the resulting biomaterials. For example, Wang et al. 
[34] prepared silk and polyvinylpyrrolidone micro- and silk fibroin nanoparticles for 
controlled drug release and concluded that release profiles can be adjusted by modu-
lating the number of β-sheets in the secondary structure of fibroin.
3. Silk biocompatibility
Silk fibroin is an attractive material for numerous biomedical applications as, 
due to its mechanical and physicochemical properties, it encompasses applica-
tions such as drug delivery, tissue engineering, and implantable devices. However, 
in addition to the functionalities necessary for specific applications, a key factor 
necessary for the clinical success of any biomaterial is the appropriate in vivo 
interactions with the body or biocompatibility. Among them, (i) the immune and 
inflammatory response and (ii) the biodegradability can be studied.
3.1 Immune and inflammatory response
As already mentioned, silk fiber is essentially made up of two proteins, fibroin 
and sericin. While fibroin is highly biocompatible [3, 4] with a low immune response 
[35, 36], sericin can present unwanted adverse allergic reactions [37, 38]. For this 
reason, sericin is normally removed by different procedures, known as degumming 
[39]. Depending on the format of the material and the location of implantation, silk 
fibroin can induce a mild inflammatory response that diminishes within a few  
hours/days after implantation [40]. The response involves the recruitment and 
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activation of macrophages and may include the activation of a mild foreign body 
response with the formation of multinucleated giant cells, again depending on 
the format of the material and the location of implantation [36]. The number of 
immune cells decreases with time, and granular tissue, if formed, is replaced by 
endogenous non-fibrous tissue, although these responses are reserved for films, 
hydrogels, and bone implants [36].
The study carried by Meinel et al. [40] indicated that collagen films implanted in 
rats produce a greater inflammatory reaction in the tissue than equivalent films pre-
pared with fibroin after 6 weeks. In another study comparing fibroin membranes 
and poly (styrene) and poly (2-hydroxyethyl methacrylate) membranes, Santin 
et al. [41] demonstrated that the former has a milder immune response than the 
latter. The results indicated that lower levels of fibrinogen were bound to the fibroin 
membrane than to the two synthetic polymers, while the same amounts of C3 
human plasma complement fragment and adsorbed IgG were detected. The activa-
tion of mononuclear cells by fibroin, measured as production of interleukin 1β, was 
lower than that of synthetic materials. Another study indicated that the braided silk 
fibroin used for the reconstruction of the anterior cruciate ligament produces a mild 
inflammatory response after seven days of implantation in vivo, while an equivalent 
implant made with the biodegradable polymer polyglycolic acid (PGA) produced 
a more acute response [42]. In this case, although the breaking load for the PGA 
implant was twice that for the fibroin graft, the initial attachment and growth of 
cells in the prosthetic ligament was higher in the latter.
In the case of silk fibroin nanoparticles, the literature is not as extensive as 
for other formats of the same material. Tan et al. [43] showed that nanoparticles 
coated with fibroin hardly produced an immune response and the adaptive 
immune system was not activated. In another study, Totten et al. [44] used in 
vitro and nuclear magnetic resonance-based metabolomics assays to examine the 
inflammatory phenotype and metabolic profiles of macrophages after exposure to 
PEGylated and unmodified silk fibroin nanoparticles. The macrophages internal-
ized both types of nanoparticles but showed different phenotypic and metabolic 
responses to each type of nanoparticle. Unmodified silk fibroin nanoparticles 
induced upregulation of several processes, including the production of pro-
inflammatory mediators (such as cytokines), the release of nitric oxide, and the 
promotion of antioxidant activity. These responses were accompanied by changes 
in macrophage metabolomic profiles that were consistent with a pro-inflammatory 
state and indicated an increase in glycolysis and reprogramming of the tricar-
boxylic acid cycle and the creatine kinase/phosphocreatine pathway. In contrast, 
PEGylated silk fibroin nanoparticles induced milder changes in inflammatory and 
metabolic profiles, suggesting that immunomodulation of macrophages with silk 
fibroin nanoparticles is dependent on PEGylation. This would indicate that the 
PEGylation of silk fibroin nanoparticles reduces the inflammatory and metabolic 
responses initiated by macrophages. In the case of silk fibroin microparticles 
(10–200 μm) prepared by enzymatic digestion, Panilaitis et al. [38] found that 
suspension of the particles induced a significant release of TNF cytokines. In con-
trast, macrophages grown in the presence of silk fibroin fibers did not upregulate 
transcription levels for a wide range of pro-inflammatory cytokines to a significant 
degree. The combination of results from these two studies could indicate that the 
immune response is dependent on the size of the biomaterial, excluding materials 
at the nanoscale and macroscale, but not at the microscale. In a recent study carried 
out in our research group [45], the HeLa and EA.hy926 cell lines were incubated 
with up to 250 μg/mL of silk fibroin nanoparticles in vitro. Viability was studied 
by MTT tests, and the results did not show significant variations (p < 0.05) with 
respect to the controls.
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Recent studies indicated that nanoparticles loaded with resveratrol have shown 
immunomodulatory properties and anti-inflammatory effects in murine models 
with inflammatory bowel disease [46] and periodontal infections [47]. In another 
similar study [48], treatments with RGD linear peptide-functionalized silk fibroin 
nanoparticles were performed and were found to improve colonic damage in rats, 
reduce neutrophil infiltration, and improve the compromised oxidative state of the 
colon. It was also found that only rats treated with RGD-silk fibroin nanoparticles 
showed a significant reduction in the expression of different pro-inflammatory 
cytokines (interleukin-1β, IL-6 and IL-12) and inducible nitric oxide synthase 
compared to the control group. Furthermore, the expression of both cytokine-
induced neutrophil chemoattractant-1 and monocyte chemotactic protein-1 was 
significantly decreased with RGD-silk fibroin nanoparticle treatment.
3.2 In vivo degradation of silk fibroin
Fibroin fibers implanted in the human body retain more than 50% of 
their mechanical properties after 60 days, which is why the North American 
Pharmacopeia classifies this material as non-biodegradable [49]. However, the 
rate at which fibroin degrades depends on the size of the implanted material, its 
morphology, mechanical and biological conditions at the implantation site, the 
secondary structure of the protein, and the molecular weight distribution of the 
fibroin chains. In particular, for the application of silk fibroin nanoparticles to drug 
transport, three of these parameters must be taken into account mainly: (i) size,  
(i) molecular weight distribution and (iii) secondary structure. But before analyz-
ing each of them, the possible degradation pathways of fibroin will be discussed to 
later mention how these parameters are able to influence degradation.
As a protein, fibroin exhibits degradation against proteases capable of degrading 
amide bonds including α-chymotrypsin, collagenase IA, protease XIV, and metal-
loproteases [50–52]. The residues of the degradation process are the corresponding 
amino acids of the proteins, so they are easily absorbed in vivo and do not generate 
toxicity. The partial hydrolysis of the protein by enzymes into small fragments is 
not a problem either, since these can be easily phagocytosed by macrophages [38]. 
Li et al. [51] observed that the mean molecular weight of fibroin film products 
after degradation with the three enzymes followed the order of protease XIV > col-
lagenase IA > α-chymotrypsin. The degradation mechanism is based on a two-stage 
process, based on enzymes finding binding domains on the surface of materials and 
their subsequent hydrolysis [53]. In this manner, different enzymes have different 
results for the degradation of different structures within fibroin. For example, 
chymotrypsin has been used to degrade the amorphous regions of fibroin to obtain 
highly crystallized fibroin [51]. Collagenase preferentially degrades the content of β 
sheets in hydrogels [38]. On the other hand, after incubation of fibroin with prote-
ase XIV, it was found that the mass was significantly reduced [51]. Brown et al. [38] 
concluded that the ability of enzymes to break down a biomaterial not only depends 
on the cleavage sites being present in the primary structure of the protein but also 
the secondary structure and the format of the material play a fundamental role. 
This indicates that the degradability of fibroin can be modulated by controlling the 
relative abundance of its secondary structures. In this way, for example, by reducing 
the content of highly crystalline structures in stacked β-sheets, degradation can be 
accelerated, since both protease XIV and chymotrypsin can act simultaneously in 
these areas.
Horan et al. [49] concluded that the degradation of electrospun fibers exhibited 
a predictable degradation dependent on the diameter of the fibers. As expected, 
as the diameter decreases and, therefore, the surface/volume ratio increases, the 
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degradation occurs at a higher rate. Decreasing the size from macroscopic fibers to 
nanoparticles will clearly increase this ratio, allowing greater access to enzymatic deg-
radation and phagocytosis by macrophages. The degradation of PEG-functionalized 
and non-functionalized silk fibroin nanoparticles by proteolytic enzymes (protease 
XIV and α-chymotrypsin) and papain, as well as cysteine protease, were studied by 
Wongpinyochit et al. [54]. Both classes of particles presented similar degradation pat-
terns in a period of 20 days, establishing the order of degradation of the particles by 
means of enzymes such as: Protease XIV > papain > > α-chymotrypsin. The authors 
reported that, after 1 day, silk fibroin nanoparticles and PEG-silk fibroin nanoparti-
cles incubated with protease XIV lost 60 and 40% of their mass, respectively, a reduc-
tion in the amorphous content of the secondary structure and an increase in diameter. 
In contrast, 10 days of incubation were required for similar degradations with papain 
and 20 with α-chymotrypsin. Silk fibroin nanoparticles were also exposed to a 
complex mixture of rat liver lysosomal enzymes ex vivo, finding that they lost 45% of 
their mass in 5 days.
Lastly, it should be noted that modifications in the molecular weight distribution 
of fibroin chains can alter the rate of degradation [55]. A decrease in this can alter 
the order of crosslinking between polymers and potentially result in faster degrada-
tion [56]. For this reason, the purification and subsequent processing of fibroin not 
only affects the mechanical and physicochemical properties of the resulting bioma-
terials [57] but can also be used to modulate their biodegradability.
4. Synthesis of silk fibroin nanoparticles
Silk fibroin particles can be produced from the top-down as well as the bottom-
up approach. The first of these involves grinding the fibroin fibers to reduce their 
size. This can be achieved through ball milling [58, 59], bead milling [60], air-jet 
[61] as well as irradiating the material with an electron beam [62]. However, these 
tend to produce particles in the micrometer range and with a wide size distribu-
tion, so in the rest of this section, we will focus on the bottom-up approach which 
offers more control over the particles produced. This approach is based on the 
self-assembly of the smallest units that constitute a nanoparticle. In the particular 
case of silk fibroin nanoparticles, the fibroin fibers are firstly dissolved to obtain 
their individual constituent units and subsequently regenerated into nanoparticle 
format. This is normally achieved through a desolvation process, which can be 
achieved in different ways that will be discussed in this section along with some 
examples; but first, the dissolution of silk fibroin will be discussed, which is not an 
easy task due to its high structural stability and deserves a detailed analysis that will 
be exposed below.
4.1 Solubilization of silk fibroin
The preparation of most biomaterials depends on achieving a complete dissolu-
tion of fibroin. This process is referred to by some authors as reverse engineering 
[63], since it attempts to obtain water-soluble fibroin with silk I structure, start-
ing from fibers with silk II structure. However, only a limited number of solvents 
are able to dissolve silk fibroin. Examples of these are strong acidic solutions 
(phosphoric, formic, sulfuric, hydrochloric) or aqueous/organic solutions concen-
trated in salts (LiCNS, LiBr, CaCl2, Ca (CNS)2, ZnCl2, NH4CNS, CuSO4, NH4OH, 
Ca(NO3)2) those that are capable of completing the dissolution of fibroin fibers 
[64–70]. This is due to the presence of the great network of intra- and intermolecu-
lar hydrogen bonds and the high crystallinity derived from its secondary structure.
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In general, the literature describes the dissolution of fibroin in concentrated salt 
solutions as a two-step process [64, 67]. In the first step, the compact, crystalline 
structure of fibroin fibers swells due to the diffusion of solvent molecules. In the 
second, the dispersion of the silk fibroin molecules begins due to the collapse of the 
intermolecular interaction and their consequent dissolution [67]. During dissolu-
tion, amorphous sections with a higher content of massive amino acid residues or 
polar groups are firstly dissolved. The cations (Ca2+, Zn2+, Cu2+, NH4
+, Li+) form 
stable chelate complexes with hydroxyl groups of the serine and tyrosine side chains 
and also with the oxygen of the carbonyls, breaking the hydrogen bonds and the 
van der Waals forces between polypeptide chains resulting in the dissolution of the 
protein that adopts silk I structure [68, 70, 71].
The described dissolution process depends on reaching a high concentration of 
salts. This entails certain disadvantages since extensive dialysis (72 h) is required 
to eliminate these, which requires 6 liters of distilled water for every 12 mL of 
solution [64]. Furthermore, the solutions obtained are unstable and tend to gel 
within a period of days. Alternatively, when long-term storage of fibroin is desired, 
aqueous fibroin solutions can be lyophilized and subsequently dissolved in organic 
solvents such as hexafluoroisopropanol [64] at the time they are to be used. 
However, these solvents are toxic and extremely corrosive so they require special 
care when handling [72].
Recently, ionic liquids have emerged as an alternative for the dissolution of silk 
fibroin [73] providing numerous advantages over traditional methods [64, 65]. 
Firstly, the negligible vapor pressure and easy recyclability of ionic liquids make 
them a more “green” alternative to organic solvents [74–76]. Secondly, the pos-
sibility of obtaining high concentrations of fibroin in a stable solution (up to 25% 
w/w in some ionic liquids [77]). Fibroin solutions in ionic liquids are more stable 
because the hydrophobic regions (highly conserved GAGAGS or GAGAGAGS 
sequences) are stabilized by the alkyl chains of cations such as imidazolium [78]. 
On the other hand, the bulky charged imidazolium ring is oriented outwards 
providing electrostatic repulsive forces between the hydrophobic blocks and 
preventing the transition from silk I to silk II through the formation of the β sheets. 
According to Wang et al. [78], solutions of silk fibroin in 1-allyl-3-methylimidazo-
lium chloride can be stable for periods longer than one and a half years. Thirdly, the 
ease with which silk fibroin can be dissolved. According to the method described 
by Lozano-Pérez et al. [77], by means of high-power ultrasound, the complete dis-
solution of fibroin can be achieved in a few minutes compared to several hours with 
traditional methods [64, 65].
4.2 Regeneration of fibroin into nanoparticles
Nanoparticle synthesis processes in a bottom-up approach involve the dissolu-
tion of fibroin in its constituent polymer units and its subsequent regeneration into 
nanoparticles. This regeneration is normally carried out by means of a desolvation 
process in an “antisolvent”, a process commonly referred to as antisolvation. As 
shown in Figure 4, in the nanoparticle synthesis process by antisolvation there are 
three key components, the polymer, the solvent and the antisolvent. The neces-
sary conditions are that: (i) the solvent and the antisolvent are miscible under the 
process conditions, while (ii) the solute must be insoluble in the solvent/antisolvent 
mixture. In this way, when mixing the polymer solution, the antisolvent will seize 
the molecules that solvate it, leading to their aggregation. Employing kinetic and 
thermodynamic controls, a limited number of polymer units can be made to aggre-
gate, thus forming nanoparticles. In practice, the preparation of nanoparticles by 
antisolvation can be achieved by different techniques that vary in the methodology 
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of mixing the solution of the polymer and the antisolvent or the nature of the latter. 
We will describe some of the most representative methods in the literature below.
4.2.1 Antisolvation in organic solvents
Probably one of the most widely used methods due to its simplicity and good 
results is the addition of the silk fibroin solution to water-miscible polar organic 
solvents, which act as an antisolvent when initiating the transition from silk I 
to silk II through the β-sheet formation [44, 77, 79–83]. It should be noted that 
the inverse variant, where the antisolvent is added to the fibroin solution, is also 
frequently found in the literature [84–86].
As an example, Wongpinyochit et al. [83] dissolved the fibroin fibers in a 9.3 M 
LiBr solution, keeping them stirred for 4 hours at 60°C. Subsequently, the solution 
is dialyzed for 72 hours and centrifuged to remove insoluble residues. Then, the 
fibroin concentration is adjusted to 5% w/v and added dropwise (10 μl/drop at a 
speed of 50 drops/min) to acetone under strong agitation, the volume of acetone 
being greater than 75% of the final volume of both liquids. A white suspension 
is immediately formed upon contact of both liquids, marking the formation of 
the nanoparticles. The particles are washed and collected by centrifugation. The 
overall process is illustrated in Figure 5. An average diameter of ca. 100 nm and a 
Z-potential of -50 mV (in distilled water) are provided for the particles obtained.
One way to optimize the nanoparticle synthesis process is to reduce the mixing 
time between the fibroin solution and the antisolvent [87]. This can be achieved 
by reducing the size of the fibroin solution droplets (increased surface/volume 
ratio) that come into contact with the antisolvent, favoring mass transfer [87]. 
In our research group, a method has been developed that uses a coaxial injector 
where the fibroin solution flows through the center and nitrogen under pressure 
runs through the concentric cylinder, this manages to produce an aerosol with very 
small droplets [45, 88].
4.2.2 Antisolvation in supercritical fluids
A supercritical fluid is any substance that is under conditions of pressure and 
temperature above its critical point. Under these conditions, the substance has 
hybrid properties between a liquid and a gas, that is, it can diffuse like a gas, and 
dissolve substances like a liquid [89]. Assuming that the compound to be used as a 
supercritical fluid meets the conditions described at the beginning of this section, 
it can act as an antisolvent in an antisolvation process. In this case, the process is 
known as supercritical antisolvation (SAS). In particular, carbon dioxide (CO2) 
is one, if not the most used substance as a supercritical fluid due to its moderate 
critical conditions (T = 304 K and P = 7.38 MPa), harmless to the operator and the 
environment, as well as its economic obtaining and operation [89].
Figure 4. 
Key components in the antisolvation process.
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The SAS process is well known and has been used for the preparation of silk 
fibroin nanoparticles [90–92]. SAS has some variants by other acronyms: Aerosol 
Solvent Extraction System (ASES), Solution Enhanced Dispersion by Supercritical 
Fluids (SEDS), Supercritical AntiSolvent with Enhanced Mass transfer (SAS-EM). 
The main difference between these processes is in the device for injecting the solution 
and CO2. In the case of the SAS and ASES processes, the liquid solution is injected 
into the precipitation reactor through a micrometric nozzle, in the case of the SEDS 
process, the nozzle is coaxial; whereas, the SAS-EM process uses a baffle surface that 
vibrates at ultrasonic frequencies to improve the atomization of the solution [93].
This method can be exemplified by the process outlined by Xie et al. [90] for the 
preparation of curcumin-loaded silk fibroin nanoparticles by SEDS. Briefly, lyophi-
lized silk fibroin in the silk I state is dissolved in hexafluoroisopropanol together 
with curcumin. The solution is subsequently injected into a precipitation reactor 
containing CO2 at 20 MPa which will act as an antisolvent for fibroin. After the 
complete injection of the solution, a constant flow of CO2 is maintained to remove 
the hexafluoroisopropanol from the precipitation reactor. Finally, the reactor is 
depressurized and opened for the collection of the nanoparticles. The process 
produces nanoparticles with a mean diameter of less than 100 nm.
4.2.3 Electrospray
Electrospray is a technique in which an electrical potential difference is applied 
between the nozzle of an injector and a manifold, which can contain a liquid that 
acts as an antisolvent [94]. In this technique, the surface of the liquid emerging from 
a capillary subjected to electrical stress is deformed into an elongated injector that 
initially produces a series of micrometer-sized drops. Because the drops are charged, 
the repulsive forces break each drop into a group of smaller drops in a process called 
coulombic explosion [94]. Using this technique to spray a silk fibroin solution onto 
Figure 5. 
Scheme illustrating the key steps to generate a solution and obtain silk fibroin nanoparticles described by 
Wongpinyochit et al. [83]. Reprinted with permission from reference (83). Copyright 2016 MyJoVE corporation.
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aluminum foil, Gholami et al. [95] succeeded in synthesizing silk fibroin nanopar-
ticles of up to 80 nm on average. The authors showed that lower concentrations, 
lower feed rates, and longer distances between the needle and the collector led to a 
decrease in mean particle size. Increasing the voltage to 20 kV decreased the size of 
the particles but voltages higher than this produced an increase in the particle size.
4.2.4 Microfluidics
Microfluidic equipment can also be used for the preparation of nanoparticles. 
Microfluidic kits are devices, generally the size of millimeters/centimeters, that 
contain microcapillaries specially designed for mixing fluids [96, 97]. A representa-
tive image of these is shown in Figure 6. These types of equipment allow precise 
manipulation of liquids (like the dissolution of silk and the antisolvent) by means 
of the control of the parameters of the process such as the total flow, the relations 
of speed between different lines of injection, etc. The greatest advantages provided 
by this equipment are the possibility of producing particles in continuous flow and 
with a narrow size distribution.
Wongpinyochit et al. [63] have used a commercial microfluidic kit to mix a 3% 
wt solution of silk fibroin with acetone or isopropanol as an antisolvent. Through 
the use of different mixing conditions, the authors were able to control the final size 
of the nanoparticles obtained, which varied between 110 and 310 nm, with polydis-
persity and Z-potential indices between 0.1/0.25 and − 20/−30 mV, respectively.
4.2.5 Salting-out
Phase separation has also been used for the preparation of nanoparticles using 
the salting-out method. For example, by adding potassium phosphate to a solution 
of silk fibroin, Lammel et al. [98] prepared fibroin particles with sizes varying 
between 500 and 2000 nm depending on the initial concentration of fibroin in 
solution. The authors revealed that, for the formation of nanoparticles, a salt 
concentration greater than 750 mM is required, otherwise, the solution gels.
5. Mechanism of nanoparticle formation in antisolvation processes
After having explained some of the synthesis methods, it is appropriate to men-
tion the mechanism by which antisolvation can generate nano-sized particles. Upon 
Figure 6. 
Microfluidic chip made of glass. Channels are 50 μm deep and 150 μm wide (image by IX-factory STK, 2014, 
CC BY-SA 3.0; no changes were made to the original image).
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mixing the fibroin solution and the antisolvent, supersaturation occurs, leading to 
phase separation (precipitation). The mechanism can be divided into two steps, 
with a nucleation stage driven by supersaturation occurring first and then a growth 
stage. Growth can occur by two coagulation mechanisms: i) the nuclei of particles 
converge to form a larger particle or condensation and ii) the polymer units add to 
growing nuclei. This is exemplified in Figure 7. Condensation decreases supersatu-
ration by reducing the mass of solute in the mixture and therefore competes with 
nucleation. Coagulation can reduce the rate of condensation by reducing the total 
number of particles and therefore the surface area [99]. Supersaturation influences 
nucleation and growth rates to different degrees. The nucleation rate depends more 
strongly on supersaturation than the condensation rate. High nucleation rates offer 
the potential to produce a large number of submicron particles in the final suspen-
sion if growth can be controlled. This process can be compared with the formation 
of crystals in the order of millimeters for X-ray crystallography when it is sought to 
obtain a low number of nuclei and greater growth in slow nucleation processes.
The key to generate rapid nucleation is to achieve rapid supersaturation. This 
process will be directly influenced by mixing and phase separation, which can be 
represented by the Damkohler number (Da) defined as the relationship between 
the mixing time (
mix







Under poor mixing conditions, 
mix
t  is large (as is Da) and the nucleation rate is 
slow relative to the growth rate, resulting in large particles and wide size distribu-
tions. As the 
mix
t  is reduced with respect to the 
.
t , greater supersaturation and 




t  can be reduced by reducing the size of the droplets (increasing the 
surface/volume ratio) of fibroin solution that meet the antisolvent, favoring mass 
transfer. Reduction in droplet size is typically achieved by increasing Reynolds 
number which produces turbulent flow and thus results in dissolution jet 
Figure 7. 
Scheme representing the mechanism of precipitation by nucleation and growth of particles by coagulation and 
condensation.
Nanostructured Materials - Classification, Growth, Simulation, Characterization, and Devices
14
fragmentation. In fact, this is the goal of previously proposed methods such as 
the coaxial injector [45, 88], SEDS [90], electrospray [95] and microfluidic 
equipment [63].
According to Eq. (1), another strategy to reduce Da is to increase the 
.
t . This can 
be achieved by adding stabilizers that interact with the polymer units generating 
steric hindrances that retard growth by condensation and coagulation [87]. 
According to Matteucci et al. [87], adding the stabilizers to the antisolvent is more 
effective in preventing the growth of the particles than adding them to the polymer 
solution. This is because, when placed in the antisolvent, the stabilizing agents are 
more available to interact with the polymeric units, as they do not need to diffuse 
across the interface from the overall aqueous phase to the organic phase.
Temperature is another important thermodynamic control factor for the 
preparation of nanoparticles by antisolvation that affects the formation of particles 
in different ways. Firstly, an increase in temperature leads to an increase in the 
solubility of the polymer and therefore reduces the degree of supersaturation when 
mixing the solutions, favoring slow nucleation. Secondly, elevated temperatures 
increase diffusion and growth kinetics at the interface of the particle boundary 
layer. And thirdly, higher solubility also increases Oswald’s maturation rate [100]. 
For these reasons, a reduced temperature in the precipitation stage is preferable for 
the formation of small nanoparticles.
6. Nanoparticle drug loading
The loading of drugs can be carried out mainly by two approaches, (i) during the 
nanoparticle formation process or (ii) a posteriori, by adsorption of the drug on the 
surface of the nanoparticle. The first approach can be achieved by adding the drug to 
the polymer solution (nanoparticle matrix) [88] or the antisolvent [101] before mix-
ing both. This approach is often referred to as coprecipitation because the polymer 
and drug precipitate together. In contrast to this method, adsorption of the drug to 
the surface of the nanoparticle can be achieved by incubating the nanoparticles in a 
solution of the drug. These methods have advantages and disadvantages. On the one 
hand, the first method is usually simpler, since the loading and preparation of the 
nanoparticle are carried out in a single step. However, this process could affect the 
formation of the nanoparticle and therefore the second method could be preferen-
tial. On the other hand, drug release profiles must be considered. As demonstrated 
by Montalbán et al. [88], particles charged by coprecipitation have slower release 
profiles compared to particles charged by absorption. This is to be expected since, 
in the latter, the drug is on the surface of the nanoparticle and readily available to 
the medium.
Drug loading and encapsulation efficiency depend on drug-polymer interac-
tions and the presence of functional groups (i.e, hydroxyl, carboxyl, etc.) in both. 
Montalbán et al. [102] used computational methods such as blind docking and 
molecular dynamics simulations to study the interactions of different drugs with 
silk fibroin nanoparticles. The authors found a strong correlation between drug-
fibroin interactions and their loading content. Similarly, drugs with weaker interac-
tions had a higher release rate and a higher percentage of loaded drug release.
7. Conclusions
Silk fibroin of the Bombyx mori silkworm is a natural, protein polymer that 
presents an interesting combination of mechanical properties, such as flexibility 
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and resistance which are still difficult to achieve with synthetic polymers. 
Furthermore, fibroin is biodegradable and biocompatible, which makes it an 
excellent material for the production of nanoparticles for drug delivery.
Although the remarkable mechanical resistance of fibroin is one of the attractive 
properties of the biomaterial, the nanoparticle synthesis process is hampered by its 
high stability, due to the high number of hydrogen bonds in its secondary structure, 
mostly in the form of antiparallel β-sheets. A recent method, developed by our 
research group, is based on the use of ionic liquids to dissolve native fibroin and has 
allowed the production of nanoparticles in an easy and scalable process for industry.
The silk fibroin nanoparticle synthesis process comprises several stages. Firstly, 
the fibroin is purified by removing the sericin (a method known as degumming). 
Secondly, fibroin must be dissolved in its monomeric units and, subsequently, 
regenerated into nanoparticles. Each of these steps can have significant effects on 
the secondary structure of the protein and given the implications that it has on the 
resistance, degradability and biocompatibility of the final product, their study is 
essential.
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